Showing results 12 to 31 of 101
< previous
next >
| Issue Date | Title | Author(s) |
| 2017-08-01 | Cannabidiol in the management of in-patient cannabis withdrawal: Clinical case series | Pokorski, I; Clement, N; Phung, N; Weltman, M; Fu, S; Copeland, J |
| 2011-12-01 | The Cannabis Withdrawal Scale development: Patterns and predictors of cannabis withdrawal and distress | Allsop, DJ; Norberg, MM; Copeland, J; Fu, S; Budney, AJ |
| 2017-08-01 | Catalytic oxidant scavenging by selenium-containing compounds: Reduction of selenoxides and N-chloramines by thiols and redox enzymes | Carroll, L; Pattison, DI; Fu, S; Schiesser, CH; Davies, MJ; Hawkins, CL |
| - | Cathinone Test | Fu, S; Philp, M; Shimmon, R |
| 2021-02-01 | Cerebrospinal fluid metabolites in tryptophan-kynurenine and nitric oxide pathways: biomarkers for acute neuroinflammation. | Yan, J; Kuzhiumparambil, U; Bandodkar, A; Bandodkar, S; Dale, RC; Fu, S |
| 2021 | Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease. | Yan, J; Kuzhiumparambil, U; Bandodkar, S; Dale, RC; Fu, S |
| 2017-10-01 | Characterization of hallucinogenic phenethylamines using high-resolution mass spectrometry for non-targeted screening purposes | Pasin, D; Cawley, A; Bidny, S; Fu, S |
| 2023-01-01 | Cocaine | Alonzo, M; Fu, S; Houck, MM |
| 2019-01-01 | Collision-induced dissociation studies of synthetic opioids for non-targeted analysis | Klingberg, J; Cawley, A; Shimmon, R; Fu, S |
| 2018-02-05 | Color spot test as a presumptive tool for the rapid detection of synthetic cathinones | Philp, M; Shimmon, R; Tahtouh, M; Fu, S |
| 2012-01 | Color tests for the preliminary identification of methcathinone and analogues of methcathinone | Toole, KE; Fu, S; Shimmon, R; Kraymen, N; Casamento, SG |
| 2018-01-01 | Color Tests for the Preliminary Identification of New Psychoactive Substances | Toole, K; Philp, M; Krayem, N; Fu, S; Shimmon, R; Taflaga, S |
| 2022-07-01 | Comparison between human liver microsomes and the fungus Cunninghamella elegans for biotransformation of the synthetic cannabinoid JWH-424 having a bromo-naphthyl moiety analysed by high-resolution mass spectrometry | Watanabe, S; Iwai, T; Matsushita, R; Nakanishi, T; Kuzhiumparambil, U; Fu, S; Seto, Y |
| 2021-01-01 | Comparison of commercial surface-enhanced Raman spectroscopy substrates for the analysis of cocaine. | Alder, R; Xiao, L; Fu, S |
| 2022-09 | Complementary biomarker detection for bisphosphonate use in racehorses | Tou, K; Cawley, A; Bishop, D; Bowen, C; Noble, G; Fu, S |
| 2017-10-01 | Current applications of high-resolution mass spectrometry for the analysis of new psychoactive substances: a critical review | Pasin, D; Cawley, A; Bidny, S; Fu, S |
| 2016-04 | Data on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans | Watanabe, S; Kuzhiumparambil, U; Winiarski, Z; Fu, S |
| 2016-06-01 | Data on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans | Watanabe, S; Kuzhiumparambil, U; Winiarski, Z; Fu, S |
| 2019-08-01 | Data on the optimisation and validation of a liquid chromatography-high-resolution mass spectrometry (LC-HRMS) to establish the presence of phosphodiesterase 5 (PDE5) inhibitors in instant coffee premixes | Mohd Yusop, AY; Xiao, L; Fu, S |
| 2019-11-01 | Determination of phosphodiesterase 5 (PDE5)inhibitors in instant coffee premixes using liquid chromatography-high-resolution mass spectrometry (LC-HRMS) | Mohd Yusop, AY; Xiao, L; Fu, S |
